Synthesis and Characterization of Vincristine and ε-Viniferin-Loaded Folate-Conjugated PLGA–PEG Nanoparticles and Their Cytotoxic and Apoptotic Effects on Liver Cancer Cells
ACS Omega · 05.05.2026 · 11 (17) · 25128-25138
DOI: 10.1021/acsomega.5c10848 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 23.04.2026. Verfasst von Yüksel Öğünç Keçeci und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Anadolu University, Tepebaşı, Eskişehir 26120, Türkiye. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anadolu ?niversitesi.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Pharmacy, Anadolu University, Tepebaşı, Eskişehir 26120, Türkiye.
- Department of Pharmaceutical Technology, Faculty of Pharmacy, Anadolu University, Tepebaşı, Eskişehir 26120, Türkiye.
ORCID-Profile: Yüksel Öğünç Keçeci
Förderung
- Anadolu ?niversitesi
Zitieren
APA
Öğünç Keçeci, Y., Demirel, M., & Seller, Z. (2026). Synthesis and Characterization of Vincristine and ε-Viniferin-Loaded Folate-Conjugated PLGA–PEG Nanoparticles and Their Cytotoxic and Apoptotic Effects on Liver Cancer Cells. ACS Omega, 11(17), 25128-25138. https://doi.org/10.1021/acsomega.5c10848
Vancouver
Öğünç Keçeci Y, Demirel M, Seller Z. Synthesis and Characterization of Vincristine and ε-Viniferin-Loaded Folate-Conjugated PLGA–PEG Nanoparticles and Their Cytotoxic and Apoptotic Effects on Liver Cancer Cells. ACS Omega. 2026;11(17):25128-25138. doi:10.1021/acsomega.5c10848
BibTeX
@article{nKeeci2026,
author = {Öğünç Keçeci, Yüksel and Demirel, Müzeyyen and Seller, Zerrin},
title = {Synthesis and Characterization of Vincristine and ε-Viniferin-Loaded Folate-Conjugated PLGA–PEG Nanoparticles and Their Cytotoxic and Apoptotic Effects on Liver Cancer Cells},
journal = {ACS Omega},
year = {2026},
volume = {11},
number = {17},
pages = {25128--25138},
doi = {10.1021/acsomega.5c10848}
}
EUVIMED